Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
253 Results for "
BChE
" in MedChemExpress (MCE) Product Catalog:
Products (253)
253 Results for "BChE" in MCE Product Catalog:
Cat. No.: HY-N10486
CAS No.: 2185837-61-8
Category:
Bletilla striata (Thunb. ex Murray) Rchb. f. Neurological Disease Orchidaceae Extract Phenols Polyphenols Plants Disease Research Fields
Target:
Cat. No.: HY-N10489
CAS No.: 136966-86-4
Target:
Cat. No.: HY-163175
CAS No.: 3037216-33-1
Target:
Research Areas:
BChE-IN-24 is a selective and reversible BChE inhibitor with an IC50 of 9 nM. BChE-IN-24 can be used for the research of Alzheimer’s disease and related neurodegenerative disorders .
Cat. No.: HY-155368
CAS No.: 1428439-79-5
Target:
Research Areas:
BChE-IN-20 (compound 7c) is a highly potent BChE-selective inhibitor and exhibits IC50s of 105 and 2.3 nM for eqBChE and hBChE, respectively. BChE-IN-20 inhibits P glycoprotein with IC50 of 0.27 μM. BChE-IN-20 is a promising template to improve design and development of BChE-selective ligands of pharmaceutical interest, including inhibitors and fluorogenic probes.
Cat. No.: HY-157520
CAS No.: 79183-25-8
Target:
Research Areas:
BChE-IN-25 (compound 4I) is a selective BChE inhibitor (IC50: 3.77μM), which is 22 times more selective for BChE than AChE .
Cat. No.: HY-175211
Target:
Research Areas:
BChE-IN-42 (Compound 4a) is a BChE inhibitor with an IC50 of 10.01 nM. BChE-IN-42 can be used for neurological diseases like Alzheimer's disease (AD) research .
Cat. No.: HY-179122
CAS No.: 425611-45-6
Target:
Research Areas:
BChE-IN-45 (compound 4p) is a competitive (cholinesterase) dual acting inhibitor (Ki = 11.13 μM). BChE-IN-45 has an IC50 of 13.8 μM for BChE and 35.63 μM for AChE. BChE-IN-45 can be used for research on Alzheimer's disease .
Cat. No.: HY-163441
Target:
Research Areas:
BChE-IN-31 (Compound 14d) is a selective BChE inhibitor with an IC50 of 65 nM. BChE-IN-31 inhibits the self-induced aggregation of neurotoxic amyloid-β (Aβ) peptide .
Cat. No.: HY-147859
CAS No.: 2653349-78-9
Target:
Research Areas:
BChE-IN-8 (compound 20) is an orally active, potent and BBB-penetrated BChE (butyrylcholinesterase) inhibitor, with IC50 values of 0.15 nM (eqBChE, equine serum BChE) and 45.2 nM (hBChE), respectively. High stability of BChE-IN-8 contributes to significantly improved blood concentration and tissue exposure. BChE-IN-8 can exert neuro-protecting and cognition improving properties through multiple modulations, including cholinergic system, Aβ aggregation, neuropeptide levels. BChE-IN-8 can be used for Alzheimer's disease (AD) research .
Cat. No.: HY-N10701
CAS No.: 80443-12-5
Target:
Cat. No.: HY-146665
CAS No.: 2410992-68-4
Target:
Research Areas:
AChE/BChE-IN-5 (BMC-16) is a dual AChE and BChE inhibitor with IC50 values of 266 nM and 10.6 nM against human AChE (hAChE) and human BChE (hBChE), respectively. AChE/BChE-IN-5 can cross the BBB .
Cat. No.: HY-161508
CAS No.: 3036136-22-5
Target:
Research Areas:
AChE/BChE-IN-19 (Compound 12) is a nicotinic hydrazide derivative. AChE/BChE-IN-19 is a inhibitor of AChE (IC50 = 21.45 nM) and BChE (IC50 =18.42 nM). AChE/BChE-IN-19 can be used in Alzheimer's disease research .
Cat. No.: HY-149484
Target:
Research Areas:
AChE/BChE-IN-15 (Compound 6d) is an AChE/BChE inhibitor, with IC50s of 20 nM and 220 nM respectively. AChE/BChE-IN-15 binds to both catalytic anionic site (CAS) and peripheral anionic site (PAS) in the active sites of AChE and BChE. AChE/BChE-IN-15 can be used for research of Alzheimer’s disease .
Cat. No.: HY-156031
Target:
Research Areas:
BChE-IN-19 (Compound 7b) is a para-substituted derivative of indone (7b) with inhibitory activity of butyryl cholinesterase (BChE) (IC50=0.04 μM). BChE-IN-19 improves cholinergic scheduling in the nervous system. BChE-IN-19 can be used against Alzheimer's disease .
Cat. No.: HY-161156
Target:
Research Areas:
BChE-IN-26 (Compound 7b) is a selective AChE and BChE inhibitor with Ki value of 35 μM and 1.6 μM. BChE-IN-26 has cytotoxicity to human neuroblastoma (SH-SY5Y) cell line. BChE-IN-26 can be used for the research of Alzheimer’s disease .
Cat. No.: HY-144689
CAS No.: 3033413-58-7
Target:
Research Areas:
BChE-IN-3 (compound 45a) is a potent, selective, time-dependent and pseudoirreversible BChE inhibitor, with an IC50 of 56.9 nM. BChE-IN-3 also shows marginal and reversible (not time-dependent) inhibition of AChE .
Cat. No.: HY-N12027
Category:
Alkaloids Annonaceae Extract Fissistigma polyanthum (Hook. f. et Thoms.) Merr. Plants Isoquinoline Alkaloids
Target:
Cat. No.: HY-144753
CAS No.: 2761991-42-6
Target:
Research Areas:
AChE/BChE-IN-2 (Compound 13b) is a potent inhibitor of AChE/BChE (AChE IC50 = 0.96 ± 0.14 µM, BChE IC50 = 1.23 ± 0.23 µM). AChE/BChE-IN-2 has the potential for the research of AD diseases .
Cat. No.: HY-161311
Research Areas:
AChE/BChE-IN-18 (Compound 4g) is a dual inhibitor of AChE/BChE , with a IC50 value of 0.315 μM for AchE. AChE/BChE-IN-18 is also a CB2R antagonist with a Ki value of 31 nM. AChE/BChE-IN-18 has neuroprotective activity .
Cat. No.: HY-174464
Target:
Research Areas:
AChE/BChE-IN-28 (Compound 5q) is a BChE inhibitor with an IC50 of 13.49 μM. AChE/BChE-IN-28 also exerts moderate inhibitory effect on AChE, with an IC50 of 35.23 μM. AChE/BChE-IN-28 can be used in the research of Alzheimer's disease .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
